Higher MICs (>2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> Treated With Ceftolozane/Tazobactam.

Open Forum Infect Dis · 2019 · PMC6810667 · PMID 31660373

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, the 12%–20% greater 30-day mortality between patients receiving SDo and HDo observed across the entire MIC range did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.